This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study is directly about Bipolarity.
BipolarityDrug
Countries
Bulgaria, Croatia, Poland
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This study is not recruiting in the United Kingdom. It is testing MRC Multicentre randomised controlled trial of cognitive behaviour therapy for Bipolarity.
This study is looking at a support or therapy approach for people with bipolarity or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.
This study is looking at a support or therapy approach for people with bipolarity or Mental and Behavioural Disorders. Participants take part in the program or support approach and complete follow-up assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.